Abstract
Physeal injuries may lead to the formation of a bone bridge resulting in limb length discrepancies and angular deformity in children. Current treatment of physeal injuries may be challenging. A number of strategies have been used to repair physeal defects with varying results. Biological regeneration using stem cells is therefore an attractive potential future option to repair physeal defects. Preclinical animal studies using stem cells have shown mixed results. Studies have investigated the use of various scaffolds including chitin, collagen and gelfoam. Significant progress has been made in discovering appropriate growth factors such as transforming growth factor (TGF-), insulin-like growth factor (IGF-1), bone morphogenetic proteins (BMPs) and fibroblast growth factor (FGF-2) that could induce physeal repair and be used in combination with stem cell therapy. Advances have been made in the use of gene therapy to maintain sustainable delivery of growth factors to injury sites. This review discusses the current stem cell therapy available to repair physeal injuries.
Keywords: Cartilage, chondrocytes, differentiation, growth plate, physis, scaffolds, stem cells.
Current Stem Cell Research & Therapy
Title:Applications of Stem Cell Therapy for Physeal Injuries.
Volume: 8 Issue: 6
Author(s): Anita Sanghani, Mukai Chimutengwende-Gordon, Adetola Adesida and Wasim Khan
Affiliation:
Keywords: Cartilage, chondrocytes, differentiation, growth plate, physis, scaffolds, stem cells.
Abstract: Physeal injuries may lead to the formation of a bone bridge resulting in limb length discrepancies and angular deformity in children. Current treatment of physeal injuries may be challenging. A number of strategies have been used to repair physeal defects with varying results. Biological regeneration using stem cells is therefore an attractive potential future option to repair physeal defects. Preclinical animal studies using stem cells have shown mixed results. Studies have investigated the use of various scaffolds including chitin, collagen and gelfoam. Significant progress has been made in discovering appropriate growth factors such as transforming growth factor (TGF-), insulin-like growth factor (IGF-1), bone morphogenetic proteins (BMPs) and fibroblast growth factor (FGF-2) that could induce physeal repair and be used in combination with stem cell therapy. Advances have been made in the use of gene therapy to maintain sustainable delivery of growth factors to injury sites. This review discusses the current stem cell therapy available to repair physeal injuries.
Export Options
About this article
Cite this article as:
Sanghani Anita, Chimutengwende-Gordon Mukai, Adesida Adetola and Khan Wasim, Applications of Stem Cell Therapy for Physeal Injuries., Current Stem Cell Research & Therapy 2013; 8 (6) . https://dx.doi.org/10.2174/1574888X1130800063
DOI https://dx.doi.org/10.2174/1574888X1130800063 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Interactions Between Diabetes Mellitus and Myelodysplastic Syndromes: Current State of Evidence and Future Directions
Current Diabetes Reviews Glucose Sensing in Chondrocytes via GLUT1 and GLUT3: Implications for Articular Cartilage and Intervertebral Disc Metabolism
Current Rheumatology Reviews Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases
Current Drug Targets Biology of Mesenchymal Stem Cells
Current Rheumatology Reviews Cardiovascular Effects of Methotrexate in Rheumatoid Arthritis Revisited
Current Medicinal Chemistry Thyroid Disorders and Prognosis in Chronic Heart Failure: A Long-Term Follow-Up Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Crucial Role of Interferon-γ and Stimulated Macrophages in Cardiovascular Disease
Current Vascular Pharmacology The Chromogranin A-Derived Vasostatins: New Players in the Endocrine Heart
Current Medicinal Chemistry Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial [Hot Topic:Modifying Cardiovascular Risk Factors: Newer Insights and Preventive Measures (Executive Editor: Aurelio Leone)]
Current Pharmaceutical Design The C-Reactive Protein Levels in Left Ventricular Dysfunction of Different Etiology
Inflammation & Allergy - Drug Targets (Discontinued) Implications of microRNAs in the Pathogenesis of Atherosclerosis and Prospects for Therapy
Current Drug Targets Synthesis, Stereochemical Studies and Antimycobacterial Activity of New Acetyl- Hydrazine Pyridazinones
Current Organic Synthesis Nanofibers Based Tissue Engineering and Drug Delivery Approaches for Myocardial Regeneration
Current Pharmaceutical Design Ca<sup>2+</sup>/Calmodulin-Dependent Protein Kinase- II in Vasoactive Peptide- Induced Responses and Vascular Biology
Current Vascular Pharmacology Sphingolipids in Cell Signaling: Their Function as Receptor Ligands, Second Messengers, and Raft Constituents
Current Immunology Reviews (Discontinued) Prevention of Renal Complications Induced by Non- Steroidal Anti-Inflammatory Drugs
Current Medicinal Chemistry The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Current Pharmaceutical Design Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity
Mini-Reviews in Medicinal Chemistry